Back to top
more

Medtronic (MDT)

(Delayed Data from NYSE)

$90.11 USD

90.11
6,281,709

+0.43 (0.48%)

Updated Nov 6, 2024 04:00 PM ET

After-Market: $90.11 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 35% (89 out of 251)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

National Vision (EYE) Q3 Earnings Surpass Estimates

by Zacks Equity Research

National Vision (EYE) delivered earnings and revenue surprises of 140% and 0.03%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Medtronic (MDT) Outperforms Broader Market: What You Need to Know

by Zacks Equity Research

Medtronic (MDT) reachead $90.07 at the closing of the latest trading day, reflecting a +0.92% change compared to its last close.

Positive Trial Data on Symplicity RDN System Likely to Support MDT Stock

by Zacks Equity Research

Medtronic announces new long-term favorable data for its Symplicity Spyral RDN system, which has undergone a SPYRAL HTN-ON MED clinical trial.

Sundeep Ganoria headshot

Should Bioventus Stock Be in Your Portfolio Pre-Q3 Earnings?

by Sundeep Ganoria

Investors will likely focus on the sales performance of BVS across the Pain Treatments and Surgical Solutions franchises when it reports third-quarter results.

Medtronic (MDT) Ascends But Remains Behind Market: Some Facts to Note

by Zacks Equity Research

In the most recent trading session, Medtronic (MDT) closed at $90.60, indicating a +0.01% shift from the previous trading day.

Medtronic (MDT) Increases Despite Market Slip: Here's What You Need to Know

by Zacks Equity Research

Medtronic (MDT) closed the most recent trading day at $91.12, moving +0.1% from the previous trading session.

Sundeep Ganoria headshot

Bioventus Surges 73% in Three Months: Time to Buy the Stock?

by Sundeep Ganoria

BVS generates encouraging returns, driven by rapid sales growth across the Pain Treatments and Surgical Solutions franchises.

MDT vs. ABT: Which Stock Is the Better Value Option?

by Zacks Equity Research

MDT vs. ABT: Which Stock Is the Better Value Option?

Should ISRG Stock Be Part of Your Portfolio Ahead of Q3 Earnings?

by Zacks Equity Research

Intuitive Surgical's third-quarter results are likely to reflect solid performance in the company's Instruments & Accessories segment. Improving margins buoy optimism.

Medtronic (MDT) Rises Yet Lags Behind Market: Some Facts Worth Knowing

by Zacks Equity Research

In the latest trading session, Medtronic (MDT) closed at $89.36, marking a +0.57% move from the previous day.

AtriCure Gets CE Mark for EnCompass Clamp, Expands in Europe

by Zacks Equity Research

ATRC's EnCompass Clamp receives a CE Mark, enabling European surgeons to access faster, simpler heart ablation in cardiac surgeries with advanced radiofrequency technology.

GE HealthCare Acquires Intelligent Ultrasound's Clinical AI Business

by Zacks Equity Research

GEHC acquires clinical AI business to aid its ultrasound portfolio with AI-driven image analysis tools.

SNN Boosts Knee Revision Surgery With Its LEGION Hinged Knee System

by Zacks Equity Research

Smith & Nephew introduces the LEGION Hinged Knee System with OXINIUM Technology, elevating knee revision surgery through innovation.

InspireMD Gains FDA Premarket Approval for CGuard Prime Carotid Stent

by Zacks Equity Research

NSPR gains premarket approval for its CGuard Prime carotid stent system for use in United States for treating carotid artery stenosis.

CRL to Aid Lundbeck's Neurological Drug Research With AI-Backed Logica

by Zacks Equity Research

Charles River and Lundbeck sign an agreement to use Logica to advance the discovery of novel neurological drugs.

Urmimala Biswas headshot

MDT Stock Trades Near 52-Week High: Is it a Smart Buy Now?

by Urmimala Biswas

The latest rate cut should help Medtronic expand in the AFib, structural heart, robotics, neuromodulation, hypertension and diabetes markets.

How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks

by Zacks Equity Research

The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.

Intuitive Surgical Stock Declines 0.7% in a Month: Is It Losing Steam?

by Zacks Equity Research

ISRG stock has maintained an uptrend so far this year on the back of robust da Vinci portfolio performance. However, the stock has declined in the past month. Let's see if the trend might change.

The Zacks Analyst Blog JPMorgan, Medtronic, Shopify and Perma-Pipe International

by Zacks Equity Research

JPMorgan, Medtronic, Shopify and Perma-Pipe International are included in this Analyst Blog.

Mark Vickery headshot

Top Research Reports for JPMorgan Chase, Medtronic & Shopify

by Mark Vickery

Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase & Co. (JPM), Medtronic plc (MDT) and Shopify Inc. (SHOP), as well as a micro-cap stock Perma-Pipe International Holdings, Inc. (PPIH).

Medtronic (MDT) Advances But Underperforms Market: Key Facts

by Zacks Equity Research

Medtronic (MDT) concluded the recent trading session at $88.26, signifying a +0.56% move from its prior day's close.

Reasons to Retain Medtronic Stock in Your Portfolio Now

by Zacks Equity Research

Investors continue to be optimistic about Medtronic due to strength in its Neurosurgery portfolio. Yet, mounting expenses pose a threat to the company's margins.

Positive Trial Outcome for PulseSelect PFA Likely to Boost MDT Stock

by Zacks Equity Research

Medtronic presents new clinical data on the PulseSelect PFA System and marks its launch in Japan.

Phibro (PAHC) Up 2.9% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Phibro (PAHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Why Medtronic (MDT) is a Top Value Stock for the Long-Term

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.